{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-003909","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2025-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.685076+00:00","generated_at":"2026-05-27T08:34:16.483909+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Telomir-1 fully reverses oxidative stress in human cells; explores bird flu treatment","bullets":["Telomir-1 fully normalized ROS levels in human cell lines, reversing copper-induced oxidative stress.","Provided strong cellular protection against copper toxicity while maintaining cell integrity.","Effective at doses significantly lower than copper levels, indicating unique regulatory mechanism.","Company evaluating Telomir-1 as potential treatment for avian influenza (bird flu) and other viruses."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-003909","json":"https://secwatch.observer/filing/0001493152-25-003909.json","markdown":"https://secwatch.observer/filing/0001493152-25-003909.md","text":"https://secwatch.observer/filing/0001493152-25-003909.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315225003909/0001493152-25-003909-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315225003909/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T08:34:16.483909+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}